Search Results
369 items found for "Network pharmacology"
Programs (2)
- Applying Pharmacology to Drug Discovery
Thank you for your interest in the Applying Pharmacology to Drug Discovery course with Dr. objective of this course is to give the registrant a good overall understanding of the unique science of pharmacology Pharmacology is a unique discipline and is critical to drug discovery. Registrants will learn: 1. What makes each drug type unique to therapeutic pharmacology? 3. Modules: Week 1 - Fundamentals of Pharmacology Week 2 - Characterizing Agonists Week 3 - Characterizing
- Advanced data analysis for GPCR pharmacology
Main objectives: - Learning how to perform advanced GPCR pharmacology data analysis in support of drug - Understanding the pharmacology data analysis framework we use for GPCRs. The participants will increase their ability to perform, understand, and communicate GPCR pharmacology Module 1 - Concentration-response analysis: Become a CRC super-user Module 2 - Quantifying agonist pharmacology and biased agonism Module 3 - Antagonist pharmacology and binding assay analysis Module 4 - New dimensions
Posts (199)
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
October 2022 Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment The network pharmacology method was used to constructe the "herb-component-target" network, and elucidated The "herb-component-target" network indicated that the ingredients of Girinimbin, Gomisin B and Asarone
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
One fascinating aspect of the cellular signaling network is the crosstalk between G protein-coupled receptors
- Platelets in the NETworks interweaving inflammation and thrombosis
September 2022 "Platelets are well characterized for their indispensable role in primary hemostasis to control hemorrhage. Research over the past years has provided a substantial body of evidence demonstrating that platelets also participate in host innate immunity. The surface expression of pattern recognition receptors, such as TLR2 and TLR4, provides platelets with the ability to sense bacterial products in their environment. Platelet α-granules contain microbicidal proteins, chemokines and growth factors, which upon release may directly engage pathogens and/or contribute to inflammatory signaling. Additionally, platelet interactions with neutrophils enhance neutrophil activation and are often crucial to induce a sufficient immune response. In particular, platelets can activate neutrophils to form neutrophil extracellular traps (NETs). This specific neutrophil effector function is characterized by neutrophils expelling chromatin fibres decorated with histones and antimicrobial proteins into the extracellular space where they serve to trap and kill pathogens. Until now, the mechanisms and signaling pathways between platelets and neutrophils inducing NET formation are still not fully characterized. NETs were also detected in thrombotic lesions in several disease backgrounds, pointing towards a role as an interface between neutrophils, platelets and thrombosis, also known as immunothrombosis. The negatively charged DNA within NETs provides a procoagulant surface, and in particular NET-derived proteins may directly activate platelets. In light of the current COVID-19 pandemic, the topic of immunothrombosis has become more relevant than ever, as a majority of COVID-19 patients display thrombi in the lung capillaries and other vascular beds. Furthermore, NETs can be found in the lung and other tissues and are associated with an increased mortality. Here, virus infiltration may lead to a cytokine storm that potently activates neutrophils and leads to massive neutrophil infiltration into the lung and NET formation. The resulting NETs presumably activate platelets and coagulation factors, further contributing to the subsequent emergence of microthrombi in pulmonary capillaries. In this review, we will discuss the interplay between platelets and NETs and the potential of this alliance to influence the course of inflammatory diseases. A better understanding of the underlying molecular mechanisms and the identification of treatment targets is of utmost importance to increase patients’ survival and improve the clinical outcome." Read more at the source #DrGPCR #GPCR #IndustryNews
Other Pages (167)
- Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking
pharmacology and molecular docking Published date October 28, 2024 Abstract "G Protein-Coupled Receptors Integrated approach combined network pharmacology and molecular docking to identify and validate the underlying pharmacological mechanisms. Subsequently, we established a protein-protein interaction (PPI) network by mapping the shared targets pharmacology Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News
- S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
Their network analysis uncovered significant clusters, emphasizing the interconnectedness of the S1P Network pharmacology analysis identified six herbal compounds-ampelopsin, ellagic acid, colchicine, epigallocatechin
- Elucidation of active components and target mechanism in Jinqiancao granules for the treatment of prostatitis and benign prostatic hyperplasia
Database-driven data mining and networking were utilized to establish a general correlation between Jinqiancao An experiment-based network reflected a pharmacological relationship between Jinqiancao granules and Xinmiao Liang Tags Benign prostatic hyperplasia , G-protein coupled receptor , Jinqiancao granules , Network pharmacology , Prostatitis Source Contribute to the GPCR News Coming soon Become a Contributor Classified